stockrowGlaukos Corporation
GKOS Healthcare Medical Devices
Glaukos Corporation’s revenue for fiscal 2025 (year ended December 2025) was $507.4 million, up 32.3% from fiscal 2024.
- Revenue
- +58.0%
- EPS
- +110.7%
- Free cash flow
- +411.2%
- Total debt
- −2.25%
Quarter to September 2026, against a year earlier
Follow GKOS
Alert me
Glaukos Corporation (GKOS) Operating cash flow
Glaukos Corporation's operating cash flow for fiscal 2025 was −$14.8M, compared with −$61.3M in fiscal 2024. Over the twelve months to 30 September 2026 it was $47.7M. Over the past ten years it has ranged from −$61.3M (fiscal 2024) to $26.1M (fiscal 2017); the current reading is higher than 45% of that period. Glaukos Corporation ranks 36th of 149 Medical Devices companies by operating cash flow.
Operating cash flow, annual
Embed this chart
Annual newest first
| Period | Operating cash flow | Change |
|---|---|---|
| FY2025 | −$14.8M | — |
| FY2024 | −$61.3M | — |
| FY2023 | −$57.8M | — |
| FY2022 | −$33.1M | — |
| FY2021 | $24.7M | — |
| FY2020 | −$23.0M | — |
| FY2019 | −$369.0K | — |
| FY2018 | $18.9M | (27.70%) |
| FY2017 | $26.1M | 111.97% |
| FY2016 | $12.3M | — |
Quarterly newest first
| Period | Operating cash flow | Change |
|---|---|---|
| Sep 2026 | $38.6M | 160.20% |
| Jun 2026 | $14.8M | — |
| Mar 2026 | −$12.5M | — |
| Dec 2025 | $6.8M | — |
| 43 more quarters | Free account |
Against its own ten years
Operating cash flow against peers
| Company | Operating cash flow |
|---|---|
| SNN Smith & Nephew SNATS, Inc. compare | $3.1B |
| ZBH Zimmer Biomet Holdings, Inc. compare | $1.9B |
| GMED Globus Medical, Inc. compare | $925.9M |
| PODD Insulet Corporation compare | $509.0M |
| BIO.B Bio-Rad Laboratories, Inc. compare | $468.1M |
| BIO Bio-Rad Laboratories, Inc. compare | $468.1M |
| BRKR Bruker Corporation compare | $341.8M |
| PEN Penumbra, Inc. compare | $261.0M |
| GKOS Glaukos Corporation | $47.7M |
What Operating cash flow is
Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.
Reported line item
More on GKOS
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement